173 related articles for article (PubMed ID: 34500464)
1. Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.
Ito A; Nakano N; Tanaka T; Fuji S; Makiyama J; Inoue Y; Choi I; Nakamae H; Nagafuji K; Takase K; Machida S; Takahashi T; Sawayama Y; Kamimura T; Kato K; Kawakita T; Ogata M; Sakai R; Shiratori S; Uchimaru K; Inamoto Y; Utsunomiya A; Fukuda T
Blood Adv; 2021 Oct; 5(20):4156-4166. PubMed ID: 34500464
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
Yoshimitsu M; Fuji S; Utsunomiya A; Nakano N; Ito A; Ito Y; Miyamoto T; Suehiro Y; Kawakita T; Moriuchi Y; Nakamae H; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Kato K;
Biol Blood Marrow Transplant; 2020 Apr; 26(4):718-722. PubMed ID: 31821886
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation.
Tanaka T; Inamoto Y; Ito A; Watanabe M; Takeda W; Aoki J; Kim SW; Fukuda T
Hematol Oncol; 2023 Aug; 41(3):389-395. PubMed ID: 36513602
[TBL] [Abstract][Full Text] [Related]
5. Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Nath K; Lee J; Elko TA; Levy L; Preston E; Devlin SM; Ponce DM; Lin RJ; Shaffer BC; Cho C; Politikos I; Jakubowski AA; Park JH; Rampal R; Perales MA; Tallman MS; Barker JN; Berman E; Tamari R; Stein E; Giralt SA; Gyurkocza B
Am J Hematol; 2023 Dec; 98(12):1869-1876. PubMed ID: 37688521
[TBL] [Abstract][Full Text] [Related]
6. Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Kharfan-Dabaja MA; Labopin M; Brissot E; Kroger N; Finke J; Ciceri F; Deconinck E; Blaise D; Chevallier P; Gramatzki M; Ganser A; Stelljes M; Edinger M; Savani B; Ruggeri A; Sanz J; Nagler A; Mohty M
Br J Haematol; 2021 May; 193(3):592-601. PubMed ID: 33838047
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.
Ureshino H; Kusaba K; Kidoguchi K; Sano H; Nishioka A; Itamura H; Yoshimura M; Yokoo M; Shindo T; Kubota Y; Ando T; Kojima K; Sueoka E; Kimura S
Ann Hematol; 2019 Feb; 98(2):465-471. PubMed ID: 30264165
[TBL] [Abstract][Full Text] [Related]
8. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia.
Kamiunten A; Sekine M; Kameda T; Akizuki K; Tahira Y; Shide K; Shimoda H; Kato K; Hidaka T; Kubuki Y; Shimoda K
Hematol Oncol; 2018 Oct; 36(4):651-655. PubMed ID: 30117169
[TBL] [Abstract][Full Text] [Related]
9. Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.
Utsunomiya A
Front Microbiol; 2019; 10():2235. PubMed ID: 31681185
[TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma.
Yoshimitsu M; Utsunomiya A; Fuji S; Fujiwara H; Fukuda T; Ogawa H; Takatsuka Y; Ishitsuka K; Yokota A; Okumura H; Ishii K; Nishikawa A; Eto T; Yonezawa A; Miyashita K; Tsukada J; Tanaka J; Atsuta Y; Kato K;
Bone Marrow Transplant; 2019 Aug; 54(8):1266-1274. PubMed ID: 30546068
[TBL] [Abstract][Full Text] [Related]
11. Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.
Inoue Y; Nishimura N; Murai M; Matsumoto M; Watanabe M; Yamada A; Izaki M; Nosaka K; Matsuoka M
Int J Hematol; 2022 Mar; 115(3):435-439. PubMed ID: 34705226
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myelogenous Leukemia: A Comparative Analysis.
Yanada M; Konuma T; Yamasaki S; Harada K; Iwasaki M; Kobayashi A; Nishijima A; Tanaka M; Uchida N; Nakamae H; Fukuda T; Onizuka M; Ozawa Y; Sawa M; Katayama Y; Yoshioka S; Kimura T; Ichinohe T; Atsuta Y; Kanda J; Yano S
Transplant Cell Ther; 2021 Dec; 27(12):1005.e1-1005.e8. PubMed ID: 34500125
[TBL] [Abstract][Full Text] [Related]
13. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S
Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768
[TBL] [Abstract][Full Text] [Related]
14. Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
Yoshimitsu M; Tanosaki R; Kato K; Ishida T; Choi I; Takatsuka Y; Fukuda T; Eto T; Hidaka M; Uchida N; Miyamoto T; Nakashima Y; Moriuchi Y; Nagafuji K; Miyazaki Y; Ichinohe T; Takanashi M; Atsuta Y; Utsunomiya A;
Biol Blood Marrow Transplant; 2018 Apr; 24(4):832-839. PubMed ID: 29155320
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
Inoue Y; Fuji S; Tanosaki R; Inamoto Y; Tanaka T; Ito A; Okinaka K; Kurosawa S; Kim SW; Nakagama H; Fukuda T
Bone Marrow Transplant; 2018 Sep; 53(9):1105-1115. PubMed ID: 29523883
[TBL] [Abstract][Full Text] [Related]
16. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
[TBL] [Abstract][Full Text] [Related]
17. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?
Nishiwaki S; Atsuta Y; Tanaka J
Bone Marrow Transplant; 2013 Nov; 48(11):1369-76. PubMed ID: 23474804
[TBL] [Abstract][Full Text] [Related]
20. Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
Epperla N; Hamadani M; Ahn KW; He F; Kodali D; Kleman A; Hari PN; Pasquini M; Fenske TS; Craig MD; Kanate AS; Bachanova V
Biol Blood Marrow Transplant; 2018 May; 24(5):983-988. PubMed ID: 29410340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
